Aspirin ameliorates the long‐term adverse effects of doxorubicin through suppression of cellular senescence

Mingxiao Feng(Guangdong Pharmaceutical University), Minsub Shim(Midwestern University)
FASEB BioAdvances
August 21, 2019
Cited by 38


Related Papers